Insiders at Nvidia (NASDAQ: NVDA) have sold stock at a steady pace in March 2026, with transactions disclosed between March 10 and March 20 pointing to sustained profit-taking.
Notably, the transactions have emerged even as the semiconductor stock continues to face volatility in line with the broader market. Overall, NVDA shares have struggled to breach the $200 level, trading at $175 as of press time.
Now, insiders appear unfazed by the volatility, continuing a precedent set in recent years where profit-taking has surged alongside the stock’s rally over the same period.
Filings show that, as of March 25, Nvidia executives and directors have offloaded a combined $124.3 million worth of stock during the month. This figure equates to an average daily selling value of approximately $4.97 million.
A breakdown of the transactions shows two large disposals by Ajay Puri on March 10 and March 18, which together amounted to over $109 million and formed the bulk of the selling activity.
Additional sales were recorded on March 20 by Chief Financial Officer Colette Kress, who executed two transactions totaling just under $11 million.
Earlier, on March 19, Aarti Shah sold shares worth about $3.36 million, while John Dabiri reported a smaller transaction valued at roughly $555,000 on March 13.
In share terms, the combined disposals amount to 684,654 shares sold in March. The concentration of activity within a 10-day window suggests a coordinated period of liquidity-taking as trading conditions remained favorable.
Impact of insider trades
Many of these transactions were executed under pre-planned Rule 10b5-1 trading plans, which are commonly used for tax planning, diversification, or managing equity compensation after Nvidia’s strong performance in recent years.
Interestingly, there have been no insider purchases reported over the past 12 months.
Meanwhile, Wall Street analysts remain largely optimistic about Nvidia’s long-term prospects, citing strong expectations for AI demand driven by the Blackwell platform and future architectures.
Consensus NVDA price targets continue to sit well above current levels, with market observers generally viewing the selling as routine rather than a signal of concern over the company’s fundamentals.
Featured image via Shutterstock
